Sitravatinib Plus Pembrolizumab in Patients With Advanced Treatment-Naïve PD-L1+ Non-Squamous NSCLC

Clinical trial NCT04925986 · TERMINATED

Trial details

NCT number: NCT04925986
Sponsor: Sarah Goldberg
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Carcinoma, Non-Small-Cell Lung Lung Diseases Lung Neoplasms Metastatic Lung Non-Small Cell Carcinoma Stage IV Lung Non-Small Cell Cancer AJCC v7 PD-L1 Gene Mutation Advanced Treatment-Naïve PD-L1 Sitravatinib Pembrolizumab

Start date: 2022-02-10
Primary completion: 2023-06-22
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.